Nuvelo Reviews

Recommend to a friend
Approve of CEO
(no image)
Ted W. Love
1 Rating
  • Extensive corporate work with SEC filings

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Corporate Paralegal in San Carlos, CA
    Former Employee - Corporate Paralegal in San Carlos, CA

    I worked at Nuvelo full-time (More than 5 years)

    Neutral Outlook
    Approves of CEO
    Neutral Outlook
    Approves of CEO


    A company that cares about it's employees


    Deadlines are unreasonable, acquisition inevitable.

    Advice to Management

    Hirer more qualified staff

Nuvelo Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters San Carlos, CA
Size 16 to 50 Employees
Founded Unknown
Type Company - Public
Industry Unknown
Revenue $25 to $50 million (USD) per year
Competitors PDL, Genentech, Possis Medical

Nuvelo is hunting for new ways to treat acute medical conditions. Its pipeline consists of two product candidates in clinical development: anticoagulant NU172 and cell growth stimulator NU206. The company shifted gears and refocused itself after the disappointing failure of another candidate. Nuvelo is also conducting research on monoclonal antibodies to identify potential drugs to treat leukemia, acute cardiovascular disease and cancer. Nuvelo has agreed to merge with privately-held ARCA biopharma. The merger will bring ARCA's commercialization experience to the table as... More

Work at Nuvelo? Share Your Experiences


Click to Rate